Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Novel surrogate virus neutralization test reveals low serum neutralizing anti-SARS-CoV-2-S antibodies levels in mildly affected COVID-19 convalescents

View ORCID ProfileBerislav Bošnjak, Saskia Catherina Stein, Stefanie Willenzon, Anne Katrin Cordes, Wolfram Puppe, Günter Bernhardt, Inga Ravens, Christiane Ritter, View ORCID ProfileChristian R. Schultze-Florey, Nina Gödecke, Jörg Martens, Hannah Kleine-Weber, Markus Hoffmann, Anne Cossmann, Mustafa Yilmaz, Isabelle Pink, Marius M. Hoeper, Georg M.N. Behrens, Stefan Pöhlmann, Rainer Blasczyk, Thomas F. Schulz, Reinhold Förster
doi: https://doi.org/10.1101/2020.07.12.20151407
Berislav Bošnjak
1Institute of Immunology, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Berislav Bošnjak
  • For correspondence: bosnjak.berislav@mh-hannover.de foerster.reinhold@mh-hannover.de
Saskia Catherina Stein
2Institute of Virology, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefanie Willenzon
1Institute of Immunology, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Katrin Cordes
2Institute of Virology, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfram Puppe
2Institute of Virology, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Günter Bernhardt
1Institute of Immunology, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inga Ravens
1Institute of Immunology, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christiane Ritter
1Institute of Immunology, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian R. Schultze-Florey
1Institute of Immunology, Hannover Medical School, Hannover, Germany
3Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christian R. Schultze-Florey
Nina Gödecke
4Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jörg Martens
4Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannah Kleine-Weber
5German Primate Center – Leibniz Institute for Primate Research, Göttingen, Germany
6Faculty of Biology and Psychology, University Göttingen, Göttingen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Hoffmann
5German Primate Center – Leibniz Institute for Primate Research, Göttingen, Germany
6Faculty of Biology and Psychology, University Göttingen, Göttingen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Cossmann
7Clinic for Rheumatology und Immunology Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mustafa Yilmaz
8Public Health Department, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Pink
9Department of Pneumology and German Centre of Lung Research (DZL), Hannover Medical School, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marius M. Hoeper
9Department of Pneumology and German Centre of Lung Research (DZL), Hannover Medical School, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georg M.N. Behrens
7Clinic for Rheumatology und Immunology Hannover Medical School, Hannover, Germany
10German Center for Infection Research (DZIF), partner site Hannover-Braunschweig, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Pöhlmann
5German Primate Center – Leibniz Institute for Primate Research, Göttingen, Germany
6Faculty of Biology and Psychology, University Göttingen, Göttingen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rainer Blasczyk
4Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas F. Schulz
2Institute of Virology, Hannover Medical School, Hannover, Germany
10German Center for Infection Research (DZIF), partner site Hannover-Braunschweig, Hannover, Germany
11Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reinhold Förster
1Institute of Immunology, Hannover Medical School, Hannover, Germany
11Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bosnjak.berislav@mh-hannover.de foerster.reinhold@mh-hannover.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Neutralizing antibodies targeting the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) block severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry into cells using surface-expressed angiotensin-converting enzyme 2 (ACE2). We developed a surrogate neutralization test (sVNT) to assess at what degree serum antibodies interfere with the binding of SARS-CoV-2-S-RBD to ACE2. The sVNT revealed neutralizing anti-SARS-CoV-2-S antibodies in the sera of 90% of mildly and 100% of severely affected coronavirus-disease-2019 (COVID-19) convalescent patients. Importantly, sVNT results correlated strongly to the results from pseudotyped-vesicular stomatitis virus-vector-based neutralization assay and to levels of anti-SARS-CoV-2-S1 IgG and IgA antibodies. Moreover, levels of neutralizing antibodies also correlated to duration and severity of clinical symptoms, but not patient age or gender. These findings together with the sVNT will not only be important for evaluating the prevalence of neutralizing antibodies in a population but also for identifying promising plasma donors for successful passive antibody therapy.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

: This work was supported by Deutsche Forschungsgemeinschaft, DFG Excellence Strategy EXC 2155 RESIST Project ID39087428 and by funds of the state of Lower Saxony (1476103184 CORONA11/20) to RF and (1476103184 CORONA12/20) to TFS and by funds of BMBF (RAPID consortium, 01K11723D).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Studies investigating serum samples from healthy controls and COVID-19 patients were approved by the HMS institutional review board (#9001_BO_K2020 and #7901_BO_K2018).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data are available upon request to the corresponding authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 14, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Novel surrogate virus neutralization test reveals low serum neutralizing anti-SARS-CoV-2-S antibodies levels in mildly affected COVID-19 convalescents
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Novel surrogate virus neutralization test reveals low serum neutralizing anti-SARS-CoV-2-S antibodies levels in mildly affected COVID-19 convalescents
Berislav Bošnjak, Saskia Catherina Stein, Stefanie Willenzon, Anne Katrin Cordes, Wolfram Puppe, Günter Bernhardt, Inga Ravens, Christiane Ritter, Christian R. Schultze-Florey, Nina Gödecke, Jörg Martens, Hannah Kleine-Weber, Markus Hoffmann, Anne Cossmann, Mustafa Yilmaz, Isabelle Pink, Marius M. Hoeper, Georg M.N. Behrens, Stefan Pöhlmann, Rainer Blasczyk, Thomas F. Schulz, Reinhold Förster
medRxiv 2020.07.12.20151407; doi: https://doi.org/10.1101/2020.07.12.20151407
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Novel surrogate virus neutralization test reveals low serum neutralizing anti-SARS-CoV-2-S antibodies levels in mildly affected COVID-19 convalescents
Berislav Bošnjak, Saskia Catherina Stein, Stefanie Willenzon, Anne Katrin Cordes, Wolfram Puppe, Günter Bernhardt, Inga Ravens, Christiane Ritter, Christian R. Schultze-Florey, Nina Gödecke, Jörg Martens, Hannah Kleine-Weber, Markus Hoffmann, Anne Cossmann, Mustafa Yilmaz, Isabelle Pink, Marius M. Hoeper, Georg M.N. Behrens, Stefan Pöhlmann, Rainer Blasczyk, Thomas F. Schulz, Reinhold Förster
medRxiv 2020.07.12.20151407; doi: https://doi.org/10.1101/2020.07.12.20151407

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (415)
  • Dentistry and Oral Medicine (70)
  • Dermatology (48)
  • Emergency Medicine (144)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4861)
  • Forensic Medicine (3)
  • Gastroenterology (183)
  • Genetic and Genomic Medicine (676)
  • Geriatric Medicine (70)
  • Health Economics (192)
  • Health Informatics (630)
  • Health Policy (321)
  • Health Systems and Quality Improvement (206)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5343)
  • Intensive Care and Critical Care Medicine (331)
  • Medical Education (93)
  • Medical Ethics (24)
  • Nephrology (75)
  • Neurology (686)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (208)
  • Oncology (440)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (90)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (129)
  • Pediatrics (194)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (781)
  • Public and Global Health (1817)
  • Radiology and Imaging (325)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (62)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)